Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
Virology
    October 2021
  1. BYRD-LEOTIS L, Lasanajak Y, Bowen T, Baker K, et al
    SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
    Virology. 2021;562:142-148.
    >> Share

  2. TAGHIZADEH P, Salehi S, Heshmati A, Houshmand SM, et al
    Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.
    Virology. 2021;562:63-73.
    >> Share

    September 2021
  3. WELCH M, Park J, Harmon K, Zhang J, et al
    Pathogenesis of a novel porcine parainfluenza virus type 1 isolate in conventional and colostrum deprived/caesarean derived pigs.
    Virology. 2021;563:88-97.
    >> Share

  4. VERMA J, Subbarao N
    Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.
    Virology. 2021;561:107-116.
    >> Share

  5. PLAAS M, Seppa K, Gaur N, Kasenomm P, et al
    Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
    Virology. 2021;561:65-68.
    >> Share

    August 2021
  6. MENNE Z, Pliasas VC, Compans RW, Glover S, et al
    Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
    Virology. 2021;562:197-208.
    >> Share

  7. NAEMI FMA, Al-Adwani S, Al-Khatabi H, Al-Nazawi A, et al
    Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.
    Virology. 2021;560:1-7.
    >> Share

    July 2021
  8. CHEN X, Rostad CA, Anderson LJ, Sun HY, et al
    The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.
    Virology. 2021;559:1-9.
    >> Share

    June 2021
  9. ICHIMIYA T, Okamatsu M, Kinoshita T, Kobayashi D, et al
    Sulfated glycans containing NeuAcalpha2-3Gal facilitate the propagation of human H1N1 influenza A viruses in eggs.
    Virology. 2021;562:29-39.
    >> Share

  10. UEDA H, Yamakawa N, Takeuchi K
    Amino- and carboxyl-terminal ends of the bovine parainfluenza virus type 3 matrix protein are important for virion and virus-like particle release.
    Virology. 2021;561:17-27.
    >> Share

  11. SUN H, Liu J, Xiao Y, Duan Y, et al
    Pathogenicity of novel reassortant Eurasian avian-like H1N1 influenza virus in pigs.
    Virology. 2021;561:28-35.
    >> Share

  12. TERRY JS, Anderson LB, Scherman MS, McAlister CE, et al
    Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
    Virology. 2021;558:28-37.
    >> Share

  13. NAYAK K, Gottimukkala K, Kumar S, Reddy ES, et al
    Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.
    Virology. 2021;558:13-21.
    >> Share

    May 2021
  14. CASE JB, Winkler ES, Errico JM, Diamond MS, et al
    On the road to ending the COVID-19 pandemic: Are we there yet?
    Virology. 2021;557:70-85.
    >> Share

  15. DJUKIC T, Mladenovic M, Stanic-Vucinic D, Radosavljevic J, et al
    Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
    Virology. 2021;557:15-22.
    >> Share

    April 2021
  16. UPRETY T, Sreenivasan CC, Bhattarai S, Wang D, et al
    Isolation and development of bovine primary respiratory cells as model to study influenza D virus infection.
    Virology. 2021;559:89-99.
    >> Share

  17. WATERS K, Wan HJ, Han L, Xue J, et al
    Variations outside the conserved motifs of PB1 catalytic active site may affect replication efficiency of the RNP complex of influenza A virus.
    Virology. 2021;559:145-155.
    >> Share

  18. NOLAN KE, Baer LA, Karekar P, Nelson AM, et al
    Metabolic shifts modulate lung injury caused by infection with H1N1 influenza A virus.
    Virology. 2021;559:111-119.
    >> Share

  19. STAUFT CB, Lien CZ, Selvaraj P, Liu S, et al
    The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
    Virology. 2021;556:96-100.
    >> Share

  20. DETSIKA MG, Ampelakiotou K, Grigoriou E, Psarra K, et al
    A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome.
    Virology. 2021;556:79-86.
    >> Share

  21. ZHIRNOV OP, Chlanda P
    The cleavage of spike protein capital EN, Cyrilliccapital A, Cyrillic0-->capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus.
    Virology. 2021;559:86-88.
    capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus.&body=ZHIRNOV OP, Chlanda P. The cleavage of spike protein capital EN, Cyrilliccapital A, Cyrillic0-->capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus. Virology. 2021;559:86-88. https://www.ncbi.nlm.nih.gov/m/pubmed/33845247" ALT="Email" TITLE="Email"> --> >> Share

    March 2021
  22. SEEKINGS AH, Warren CJ, Thomas SS, Mahmood S, et al
    Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry.
    Virology. 2021;559:74-85.
    >> Share

  23. WOLF JJ, Xia C, Studstill CJ, Ngo H, et al
    Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.
    Virology. 2021;558:67-75.
    >> Share

  24. XIE L, Yi K, Li Y
    SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.
    Virology. 2021;558:22-27.
    >> Share

  25. LU KT, Yamamoto T, McDonald D, Li W, et al
    U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific Rim.
    Virology. 2021;555:71-77.
    >> Share

  26. TAKESHITA M, Nishina N, Moriyama S, Takahashi Y, et al
    Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
    Virology. 2021;555:35-43.
    >> Share

    February 2021
  27. NOMURA N, Matsuno K, Shingai M, Ohno M, et al
    Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.
    Virology. 2021;557:55-61.
    >> Share

  28. ABDEL-MONEIM AS, Abdelwhab EM, Memish ZA
    Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
    Virology. 2021;558:1-12.
    >> Share

  29. ISHIGAKI H, Nakayama M, Kitagawa Y, Nguyen CT, et al
    Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
    Virology. 2021;554:97-105.
    >> Share

  30. REFAEY RH, El-Ashrey MK, Nissan YM
    Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.
    Virology. 2021;554:48-54.
    >> Share

    January 2021
  31. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.
    Virology. 2021;553:154-156.
    >> Share

    December 2020
  32. MORE SA, Patil AS, Sakle NS, Mokale SN, et al
    Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
    Virology. 2020;555:10-18.
    >> Share

  33. LI L, Liang Y, Hu F, Yan H, et al
    Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Virology. 2020;551:26-35.
    >> Share

  34. JIANG RD, Li B, Liu XL, Liu MQ, et al
    Bat mammalian orthoreoviruses cause severe pneumonia in mice.
    Virology. 2020;551:84-92.
    >> Share

    November 2020
  35. YU R, Tan S, Dan Y, Lu Y, et al
    Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection.
    Virology. 2020;553:131-134.
    >> Share

  36. POWELL JD, Abente EJ, Chang J, Souza CK, et al
    Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
    Virology. 2020;553:94-101.
    >> Share

  37. JONES LR, Manrique JM
    Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
    Virology. 2020;550:70-77.
    >> Share

  38. DOBROVOLNY HM
    Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Virology. 2020;550:61-69.
    >> Share

  39. KISHKO M, Catalan J, Swanson K, DiNapoli J, et al
    Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
    Virology. 2020;550:21-26.
    >> Share

    October 2020
  40. WU T, Ge Y, Zhao K, Zhu X, et al
    A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).
    Virology. 2020;549:1-4.
    >> Share

    September 2020
  41. NISSLY RH, Zaman N, Ibrahim PAS, McDaniel K, et al
    Influenza C and D viral load in cattle correlates with bovine respiratory disease (BRD): Emerging role of orthomyxoviruses in the pathogenesis of BRD.
    Virology. 2020;551:10-15.
    >> Share

  42. SEYED HOSSEINI E, Riahi Kashani N, Nikzad H, Azadbakht J, et al
    The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.
    Virology. 2020;551:1-9.
    >> Share

  43. MOHTADI N, Ghaysouri A, Shirazi S, Sara Ansari, et al
    Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
    Virology. 2020;548:1-5.
    >> Share

    August 2020
  44. KIM KH, Jung YJ, Lee Y, Park BR, et al
    Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Virology. 2020;550:51-60.
    >> Share

  45. ILYUSHINA NA, Lee N, Lugovtsev VY, Kan A, et al
    Adaptation of influenza B virus by serial passage in human airway epithelial cells.
    Virology. 2020;549:68-76.
    >> Share

  46. NILSSON K, Abdurahman S, Schwartz S
    Influenza virus natural sequence heterogeneity in segment 8 affects interactions with cellular RNA-binding proteins and splicing efficiency.
    Virology. 2020;549:39-50.
    >> Share

  47. JERRY C, Stallknecht D, Leyson C, Berghaus R, et al
    Recombinant hemagglutinin glycoproteins provide insight into binding to host cells by H5 influenza viruses in wild and domestic birds.
    Virology. 2020;550:8-20.
    >> Share

  48. TANG J, Zhang SX, Zhang J, Li XY, et al
    Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
    Virology. 2020;549:77-84.
    >> Share

  49. MISHRA S, Goyal P, Kumar D, Chaudhari R, et al
    Experimental validation of influenza A virus matrix protein (M1) interaction with host cellular alpha enolase and pyruvate kinase.
    Virology. 2020;549:59-67.
    >> Share

  50. ROTHAN HA, Stone S, Natekar J, Kumari P, et al
    The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.
    Virology. 2020;547:7-11.
    >> Share

    July 2020
  51. SHI F, Wu T, Zhu X, Ge Y, et al
    Association of viral load with serum biomakers among COVID-19 cases.
    Virology. 2020;546:122-126.
    >> Share

    June 2020
  52. WOODS PS, Doolittle LM, Rosas LE, Nana-Sinkam SP, et al
    Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.
    Virology. 2020;545:40-52.
    >> Share

    March 2020
  53. LIU R, Sreenivasan C, Yu H, Sheng Z, et al
    Influenza D virus diverges from its related influenza C virus in the recognition of 9-O-acetylated N-acetyl- or N-glycolyl-neuraminic acid-containing glycan receptors.
    Virology. 2020;545:16-23.
    >> Share

    February 2020
  54. FANG QQ, Huang WJ, Li XY, Cheng YH, et al
    Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
    Virology. 2020;545:1-9.
    >> Share

  55. PURANIK A, Slomka MJ, Warren CJ, Thomas SS, et al
    Transmission dynamics between infected waterfowl and terrestrial poultry: Differences between the transmission and tropism of H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4a) among ducks, chickens and turkeys.
    Virology. 2020;541:113-123.
    >> Share

    January 2020
  56. MCALLISTER CS, Ansaldi D, Growcott EJ, Zhong Y, et al
    Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling.
    Virology. 2020;540:195-206.
    >> Share

  57. LUDEKE B, Fearns R
    The respiratory syncytial virus polymerase can perform RNA synthesis with modified primers and nucleotide analogs.
    Virology. 2020;540:66-74.
    >> Share

  58. ZOU S, Tang J, Zhang Y, Liu L, et al
    Molecular characterization of H3 subtype avian influenza viruses based on poultry-related environmental surveillance in China between 2014 and 2017.
    Virology. 2020;542:8-19.
    >> Share

  59. STRAUS MR, Kinder JT, Segall M, Dutch RE, et al
    SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
    Virology. 2020;543:43-53.
    >> Share

    November 2019
  60. LONDRIGAN SL, Wakim LM, Smith J, Haverkate AJ, et al
    IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages.
    Virology. 2019;540:17-22.
    >> Share

  61. RODRIGUEZ P, Marcos-Villar L, Zamarreno N, Yanguez E, et al
    Mutations of the segment-specific nucleotides at the 3' end of influenza virus NS segment control viral replication.
    Virology. 2019;539:104-113.
    >> Share

    September 2019
  62. YANG J, Xie D, Nie Z, Xu B, et al
    Inferring host roles in bayesian phylodynamics of global avian influenza A virus H9N2.
    Virology. 2019;538:86-96.
    >> Share

  63. SHENG T, Sun Y, Sun J, Prinz RA, et al
    Role of TGF-beta-activated kinase 1 (TAK1) activation in H5N1 influenza A virus-induced c-Jun terminal kinase activation and virus replication.
    Virology. 2019;537:263-271.
    >> Share

    August 2019
  64. ZHANG S, Huo C, Xiao J, Fan T, et al
    p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.
    Virology. 2019;537:110-120.
    >> Share

  65. LEYSON C, Youk SS, Smith D, Dimitrov K, et al
    Pathogenicity and genomic changes of a 2016 European H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4) in experimentally infected mallards and chickens.
    Virology. 2019;537:172-185.
    >> Share

  66. PATEL H, Kukol A
    Prediction of ligands to universally conserved binding sites of the influenza a virus nuclear export protein.
    Virology. 2019;537:97-103.
    >> Share

  67. PULIT-PENALOZA JA, Belser JA, Tumpey TM, Maines TR, et al
    Mammalian pathogenicity and transmissibility of a reassortant Eurasian avian-like A(H1N1v) influenza virus associated with human infection in China (2015).
    Virology. 2019;537:31-35.
    >> Share

  68. TROST JF, Wang W, Liang B, Galloway SE, et al
    A conserved histidine in Group-1 influenza subtype hemagglutinin proteins is essential for membrane fusion activity.
    Virology. 2019;536:78-90.
    >> Share

  69. GE Y, Chi Y, Min X, Zhao K, et al
    The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.
    Virology. 2019;536:58-67.
    >> Share

  70. DE VLUGT C, Sikora D, Rocheleau L, Pelchat M, et al
    Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA.
    Virology. 2019;536:91-100.
    >> Share

    July 2019
  71. SUN X, Belser JA, Yang H, Pulit-Penaloza JA, et al
    Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.
    Virology. 2019;535:232-240.
    >> Share

  72. HAO X, Wang X, Hu J, Gu M, et al
    The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens.
    Virology. 2019;535:218-226.
    >> Share

  73. KIM KH, Lee YT, Park S, Jung YJ, et al
    Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Virology. 2019;535:179-188.
    >> Share

    June 2019
  74. XIAO Y, Park JK, Williams S, Ramuta M, et al
    Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.
    Virology. 2019;534:96-107.
    >> Share

  75. NICHOLS JE, Niles JA, Fleming EH, Roberts NJ, et al
    The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.
    Virology. 2019;534:80-86.
    >> Share

  76. BERGMANN S, Elbahesh H
    Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses.
    Virology. 2019;534:54-63.
    >> Share

    May 2019
  77. YANG G, Chowdury S, Hodges E, Rahman MZ, et al
    Detection of highly pathogenic avian influenza A(H5N6) viruses in waterfowl in Bangladesh.
    Virology. 2019;534:36-44.
    >> Share

  78. LEE Y, Ko EJ, Kim KH, Lee YT, et al
    A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Virology. 2019;534:1-13.
    >> Share

  79. OHTA K, Matsumoto Y, Nishio M
    Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.
    Virology. 2019;533:108-114.
    >> Share

  80. MINE J, Uchida Y, Nakayama M, Tanikawa T, et al
    Genetics and pathogenicity of H5N6 highly pathogenic avian influenza viruses isolated from wild birds and a chicken in Japan during winter 2017-2018.
    Virology. 2019;533:1-11.
    >> Share

    April 2019
  81. TRIGUEIRO-LOURO JM, Correia V, Santos LA, Guedes RC, et al
    To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.
    Virology. 2019 Apr 27. pii: S0042-6822(19)30109.
    >> Share

  82. MA J, Shen H, McDowell C, Liu Q, et al
    Virus survival and fitness when multiple genotypes and subtypes of influenza A viruses exist and circulate in swine.
    Virology. 2019;532:30-38.
    >> Share

    March 2019
  83. TAKIZAWA N, Ogura Y, Fujita Y, Noda T, et al
    Local structural changes of the influenza A virus ribonucleoprotein complex by single mutations in the specific residues involved in efficient genome packaging.
    Virology. 2019;531:126-140.
    >> Share

  84. YUMINE N, Matsumoto Y, Ohta K, Fukasawa M, et al
    Claudin-1 inhibits human parainfluenza virus type 2 dissemination.
    Virology. 2019;531:93-99.
    >> Share

    February 2019
  85. REN L, Zhang W, Han P, Zhang J, et al
    Influenza A virus (H1N1) triggers a hypoxic response by stabilizing hypoxia-inducible factor-1alpha via inhibition of proteasome.
    Virology. 2019;530:51-58.
    >> Share

  86. ZHANG T, Zhao H, Wang J, Han GZ, et al
    Wild birds do not harbor higher diversity of influenza virus internal genes than poultry.
    Virology. 2019;530:59-64.
    >> Share

    January 2019
  87. SANADA T, Yasui F, Honda T, Kayesh MEH, et al
    Avian H5N1 influenza virus infection causes severe pneumonia in the Northern tree shrew (Tupaia belangeri).
    Virology. 2019;529:101-110.
    >> Share

  88. LEE YT, Kim KH, Ko EJ, Kim MC, et al
    Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
    Virology. 2019;529:111-121.
    >> Share

  89. KWON JH, Noh JY, Jeong JH, Jeong S, et al
    Different pathogenicity of two strains of clade 2.3.4.4c H5N6 highly pathogenic avian influenza viruses bearing different PA and NS gene in domestic ducks.
    Virology. 2019;530:11-18.
    >> Share

  90. JESTER B, Uyeki TM, Jernigan DB, Tumpey TM, et al
    Historical and clinical aspects of the 1918 H1N1 pandemic in the United States.
    Virology. 2019;527:32-37.
    >> Share

  91. SREENIVASAN CC, Thomas M, Antony L, Wormstadt T, et al
    Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types.
    Virology. 2019;528:152-163.
    >> Share

  92. LIU L, Wang T, Wang M, Tong Q, et al
    Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
    Virology. 2019;529:7-15.
    >> Share

  93. ZOU S, Zhang Y, Li X, Bo H, et al
    Molecular characterization and receptor binding specificity of H9N2 avian influenza viruses based on poultry-related environmental surveillance in China between 2013 and 2016.
    Virology. 2019;529:135-143.
    >> Share

  94. NIKOLAIDIS M, Mimouli K, Kyriakopoulou Z, Tsimpidis M, et al
    Large-scale genomic analysis reveals recurrent patterns of intertypic recombination in human enteroviruses.
    Virology. 2019;526:72-80.
    >> Share

    December 2018
  95. MA LL, Zhang P, Wang HQ, Li YF, et al
    heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-alpha/beta.
    Virology. 2018;528:80-88.
    >> Share

  96. OHTSUKA J, Matsumoto Y, Ohta K, Fukumura M, et al
    Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.
    Virology. 2018;528:54-63.
    >> Share

    November 2018
  97. HIONO T, Matsuda A, Wagatsuma T, Okamatsu M, et al
    Lectin microarray analyses reveal host cell-specific glycan profiles of the hemagglutinins of influenza A viruses.
    Virology. 2018;527:132-140.
    >> Share

  98. BELSER JA, Maines TR, Tumpey TM
    Importance of 1918 virus reconstruction to current assessments of pandemic risk.
    Virology. 2018;524:45-55.
    >> Share

    October 2018
  99. NICOL MQ, Campbell GM, Shaw DJ, Dransfield I, et al
    Lack of IFNgamma signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.
    Virology. 2018;526:155-164.
    >> Share

  100. WANG SC, Liao HY, Zhang JY, Cheng TR, et al
    Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Virology. 2018;526:125-137.
    >> Share

  101. ZHANG J, Ruan T, Sheng T, Wang J, et al
    Role of c-Jun terminal kinase (JNK) activation in influenza A virus-induced autophagy and replication.
    Virology. 2018;526:1-12.
    >> Share

  102. MARCHENKO V, Goncharova N, Susloparov I, Kolosova N, et al
    Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia.
    Virology. 2018;525:216-223.
    >> Share

  103. NARKPUK J, Jongkaewwattana A, Teeravechyan S
    The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin.
    Virology. 2018;525:161-169.
    >> Share

  104. GONZALEZ-PARRA G, Dobrovolny HM
    A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo.
    Virology. 2018;523:129-139.
    >> Share

  105. MORGENE MF, Maurin C, Pillet S, Berthelot P, et al
    HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics.
    Virology. 2018;523:27-34.
    >> Share

    September 2018
  106. YAN LM, Li OTW, Poh CM, Perera RAPM, et al
    Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.
    Virology. 2018;525:73-82.
    >> Share

  107. CUI L, Mahesutihan M, Zheng W, Meng L, et al
    CDC25B promotes influenza A virus replication by regulating the phosphorylation of nucleoprotein.
    Virology. 2018;525:40-47.
    >> Share

  108. LI L, DeLiberto TJ, Killian ML, Torchetti MK, et al
    Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States.
    Virology. 2018;525:32-39.
    >> Share

  109. XIAO Y, Nolting JM, Sheng ZM, Bristol T, et al
    Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.
    Virology. 2018;524:182-191.
    >> Share

  110. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    >> Share

    August 2018
  111. OHTA K, Matsumoto Y, Yumine N, Nishio M, et al
    The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
    Virology. 2018;524:90-96.
    >> Share

  112. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    >> Share

  113. SHIBATA A, Okamatsu M, Sumiyoshi R, Matsuno K, et al
    Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers.
    Virology. 2018;524:10-17.
    >> Share

    July 2018
  114. SUTTIE A, Karlsson EA, Deng YM, Horm SV, et al
    Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.
    Virology. 2018;523:22-26.
    >> Share

  115. WANG Z, Huang B, Thomas M, Sreenivasan CC, et al
    Detailed mapping of the linear B Cell epitopes of the hemagglutinin (HA) protein of swine influenza virus.
    Virology. 2018;522:131-137.
    >> Share

  116. CORREIA V, Abecasis AB, Rebelo-de-Andrade H
    Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.
    Virology. 2018;522:122-130.
    >> Share

  117. SHCHERBIK S, Carney P, Pearce N, Stevens J, et al
    Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
    Virology. 2018;522:65-72.
    >> Share

  118. GAMBARYAN AS, Matrosovich TY, Boravleva EY, Lomakina NF, et al
    Receptor-binding properties of influenza viruses isolated from gulls.
    Virology. 2018;522:37-45.
    >> Share

    May 2018
  119. LI Y, Sun L, Zheng W, Madina Mahesutihan, et al
    Phosphorylation and dephosphorylation of threonine 188 in nucleoprotein is crucial for the replication of influenza A virus.
    Virology. 2018;520:30-38.
    >> Share

    April 2018
  120. LI J, Zhang K, Chen Q, Zhang X, et al
    Three amino acid substitutions in the NS1 protein change the virus replication of H5N1 influenza virus in human cells.
    Virology. 2018;519:64-73.
    >> Share

    March 2018
  121. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Kotomina T, et al
    Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
    Virology. 2018;518:313-323.
    >> Share

  122. CHRZASTEK K, Lee DH, Gharaibeh S, Zsak A, et al
    Characterization of H9N2 avian influenza viruses from the Middle East demonstrates heterogeneity at amino acid position 226 in the hemagglutinin and potential for transmission to mammals.
    Virology. 2018;518:195-201.
    >> Share

    February 2018
  123. ZHANG S, Cheng Q, Luo C, Yin L, et al
    An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N(0)-P interaction and maintaining N solubility.
    Virology. 2018;518:64-76.
    >> Share

  124. RAMEY AM, DeLiberto TJ, Berhane Y, Swayne DE, et al
    Lessons learned from research and surveillance directed at highly pathogenic influenza A viruses in wild birds inhabiting North America.
    Virology. 2018;518:55-63.
    >> Share

  125. RAJAO DS, Anderson TK, Kitikoon P, Stratton J, et al
    Antigenic and genetic evolution of contemporary swine H1 influenza viruses in the United States.
    Virology. 2018;518:45-54.
    >> Share

    January 2018
  126. RODRIGUEZ L, Reedy S, Nogales A, Murcia PR, et al
    Development of a novel equine influenza virus live-attenuated vaccine.
    Virology. 2018;516:76-85.
    >> Share

  127. OISHI K, Yamayoshi S, Kawaoka Y
    Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast.
    Virology. 2018;516:71-75.
    >> Share

  128. LEE YN, Lee EK, Song BM, Heo GB, et al
    Evaluation of the zoonotic potential of multiple subgroups of clade 2.3.4.4 influenza A (H5N8) virus.
    Virology. 2018;516:38-45.
    >> Share

    December 2017
  129. SUN H, Yao W, Wang K, Qian Y, et al
    Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.
    Virology. 2017;514:230-239.
    >> Share

  130. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
    A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Virology. 2017;515:21-28.
    >> Share

    November 2017
  131. AUMAYR M, Schrempf A, Uzulmez O, Olek KM, et al
    Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Virology. 2017;511:123-134.
    >> Share

    October 2017
  132. NI F, Kondrashkina E, Wang Q
    Determinant of receptor-preference switch in influenza hemagglutinin.
    Virology. 2017;513:98-107.
    >> Share

  133. LION A, Richard M, Esnault E, Kut E, et al
    Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.
    Virology. 2017;513:29-42.
    >> Share

  134. LAU JW, Kim YI, Murphy R, Newman R, et al
    Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.
    Virology. 2017;510:289-296.
    >> Share

  135. YE Z, Ren L, Tang Z, Deng Y, et al
    Pulmonary C-fiber degeneration downregulates IFN-gamma receptor 1 via IFN-alpha induction to attenuate RSV-induced airway hyperresponsiveness.
    Virology. 2017;510:262-272.
    >> Share

    September 2017
  136. TAKEMAE N, Tsunekuni R, Sharshov K, Tanikawa T, et al
    Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017.
    Virology. 2017;512:8-20.
    >> Share

  137. WILSON JR, Belser JA, DaSilva J, Guo Z, et al
    An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
    Virology. 2017;511:214-221.
    >> Share

    August 2017
  138. CHEN W, Xu Q, Zhong Y, Yu H, et al
    Genetic variation and co-evolutionary relationship of RNA polymerase complex segments in influenza A viruses.
    Virology. 2017;511:193-206.
    >> Share

  139. NAGUIB MM, Arafa AS, Parvin R, Beer M, et al
    Insights into genetic diversity and biological propensities of potentially zoonotic avian influenza H9N2 viruses circulating in Egypt.
    Virology. 2017;511:165-174.
    >> Share

  140. BELSER JA, Johnson A, Pulit-Penaloza JA, Pappas C, et al
    Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.
    Virology. 2017;511:135-141.
    >> Share

  141. HWANG HS, Lee YT, Kim KH, Ko EJ, et al
    Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Virology. 2017;511:142-151.
    >> Share

  142. ABENTE EJ, Gauger PC, Walia RR, Rajao DS, et al
    Detection and characterization of an H4N6 avian-lineage influenza A virus in pigs in the Midwestern United States.
    Virology. 2017;511:56-65.
    >> Share

  143. ROJO GL, Goya S, Orellana M, Sancilio A, et al
    Unravelling respiratory syncytial virus outbreaks in Buenos Aires, Argentina: Molecular basis of the spatio-temporal transmission.
    Virology. 2017;508:118-126.
    >> Share

    July 2017
  144. NGUYEN LT, Nishi T, Shichinohe S, Chu DH, et al
    Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.
    Virology. 2017;510:252-261.
    >> Share

  145. BAJIMAYA S, Frankl T, Hayashi T, Takimoto T, et al
    Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.
    Virology. 2017;510:234-241.
    >> Share

  146. ALKHERAIF AA, Topliff CL, Reddy J, Massilamany C, et al
    Type 2 BVDV Npro suppresses IFN-1 pathway signaling in bovine cells and augments BRSV replication.
    Virology. 2017;507:123-134.
    >> Share

    June 2017
  147. SIKORA D, Rocheleau L, Brown EG, Pelchat M, et al
    Influenza A virus cap-snatches host RNAs based on their abundance early after infection.
    Virology. 2017;509:167-177.
    >> Share

  148. CHLANDA P
    Influenza Hemagglutinin and M2 ion channel priming by trypsin: Killing two birds with one stone.
    Virology. 2017;509:131-132.
    >> Share

  149. PATEL H, Kukol A
    Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
    Virology. 2017;509:112-120.
    >> Share

  150. SMITH GE, Sun X, Bai Y, Liu YV, et al
    Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
    Virology. 2017;509:90-97.
    >> Share

  151. DENG L, Kim JR, Chang TZ, Zhang H, et al
    Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
    Virology. 2017;509:82-89.
    >> Share

    May 2017
  152. WANG BX, Brown EG, Fish EN
    Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation.
    Virology. 2017;508:170-179.
    >> Share

  153. SUN X, Belser JA, Pulit-Penaloza JA, Creager HM, et al
    Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Virology. 2017;508:164-169.
    >> Share

  154. LIN CY, Chia MY, Chen PL, Yeh CT, et al
    Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan.
    Virology. 2017;508:159-163.
    >> Share

  155. XU G, Zhang X, Liu Q, Bing G, et al
    PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine.
    Virology. 2017;508:45-53.
    >> Share

    April 2017
  156. LEE DH, Torchetti MK, Killian ML, Swayne DE, et al
    Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016.
    Virology. 2017;507:216-219.
    >> Share

  157. CHUTIWITOONCHAI N, Mano T, Kakisaka M, Sato H, et al
    Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
    Virology. 2017;507:32-39.
    >> Share

  158. HILLYER P, Mane VP, Chen A, Dos Santos MB, et al
    Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.
    Virology. 2017;504:63-72.
    >> Share

    March 2017
  159. NARKPUK J, Teeravechyan S, Puthavathana P, Jongkaewwattana A, et al
    Single nucleoprotein residue determines influenza A virus sensitivity to an intertypic suppression mechanism.
    Virology. 2017;506:99-109.
    >> Share

  160. FOUGEROLLE S, Legrand L, Lecouturier F, Sailleau C, et al
    Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.
    Virology. 2017;505:210-217.
    >> Share

    February 2017
  161. CHEN LJ, Lin XD, Tian JH, Liao Y, et al
    Diversity, evolution and population dynamics of avian influenza viruses circulating in the live poultry markets in China.
    Virology. 2017;505:33-41.
    >> Share

  162. CHAIMAYO C, Hayashi T, Underwood A, Hodges E, et al
    Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.
    Virology. 2017;505:23-32.
    >> Share

  163. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
    A live-attenuated influenza vaccine for H3N2 canine influenza virus.
    Virology. 2017;504:96-106.
    >> Share

    January 2017
  164. LEE YH, Jang YH, Seong BL
    Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Virology. 2017;504:73-78.
    >> Share

  165. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
    Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Virology. 2017;503:83-93.
    >> Share

  166. RABBANI MA, Barik S
    5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus.
    Virology. 2017;503:46-51.
    >> Share

  167. KIM SH, Paldurai A, Samal SK
    A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Virology. 2017;503:31-36.
    >> Share

    December 2016
  168. PEARCE MB, Pappas C, Gustin KM, Davis CT, et al
    Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets.
    Virology. 2016;502:114-122.
    >> Share

  169. SUPTAWIWAT O, Ninpan K, Boonarkart C, Ruangrung K, et al
    Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
    Virology. 2016;502:84-96.
    >> Share

  170. BELSER JA, Sun X, Creager HM, Johnson A, et al
    Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.
    Virology. 2016;502:13-19.
    >> Share

  171. PUSHKO P, Tretyakova I, Hidajat R, Zsak A, et al
    Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
    Virology. 2016;501:176-182.
    >> Share

  172. BAJIMAYA S, Hayashi T, Frankl T, Bryk P, et al
    Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.
    Virology. 2016;501:127-135.
    >> Share

    November 2016
  173. HU M, Yuan S, Zhang K, Singh K, et al
    PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals.
    Virology. 2016;501:92-101.
    >> Share

  174. LUO J, Ferguson L, Smith DR, Woolums AR, et al
    Serological evidence for high prevalence of Influenza D Viruses in Cattle, Nebraska, United States, 2003-2004.
    Virology. 2016;501:88-91.
    >> Share

  175. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Tretiak T, et al
    Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
    Virology. 2016;500:209-217.
    >> Share

  176. KOSIK I, Yewdell JW
    Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.
    Virology. 2016;500:178-183.
    >> Share

  177. GONZALEZ Y, Juarez E, Carranza C, Sada E, et al
    Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus.
    Virology. 2016;500:139-148.
    >> Share

  178. HARTWIG SM, Ketterer M, Apicella MA, Varga SM, et al
    Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.
    Virology. 2016;498:128-35.
    >> Share

    October 2016
  179. GUJJAR N, Chothe SK, Gawai S, Nissly R, et al
    Co-expression of sialic acid receptors compatible with avian and human influenza virus binding in emus (Dromaius novaehollandiae).
    Virology. 2016;500:114-121.
    >> Share

  180. CREAGER HM, Zeng H, Pulit-Penaloza JA, Maines TR, et al
    In vitro exposure system for study of aerosolized influenza virus.
    Virology. 2016;500:62-70.
    >> Share

  181. NOGALES A, Huang K, Chauche C, DeDiego ML, et al
    Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Virology. 2016;500:1-10.
    >> Share

  182. ELBAHESH H, Bergmann S, Russell CJ
    Focal adhesion kinase (FAK) regulates polymerase activity of multiple influenza A virus subtypes.
    Virology. 2016;499:369-374.
    >> Share

  183. GARG R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S, et al
    A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
    Virology. 2016;499:288-297.
    >> Share

  184. SHRIVASTAVA P, Sarkar I, Atanley E, Gomis S, et al
    IL-12p40 gene-deficient BALB/c mice exhibit lower weight loss, reduced lung pathology and decreased sensitization to allergen in response to infection with pneumonia virus of mice.
    Virology. 2016;497:1-10.
    >> Share

    September 2016
  185. CUI P, Deng G, Shi J, Kong H, et al
    New influenza A(H7N7) viruses detected in live poultry markets in China.
    Virology. 2016;499:165-169.
    >> Share

  186. DEJESUS E, Costa-Hurtado M, Smith D, Lee DH, et al
    Changes in adaptation of H5N2 highly pathogenic avian influenza H5 clade 2.3.4.4 viruses in chickens and mallards.
    Virology. 2016;499:52-64.
    >> Share

  187. ISHIKAWA H, Fukui T, Ino S, Sasaki H, et al
    Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
    Virology. 2016;499:23-29.
    >> Share

  188. RAUFF D, Strydom C, Abolnik C
    Evolutionary consequences of a decade of vaccination against subtype H6N2 influenza.
    Virology. 2016;498:226-239.
    >> Share

    April 2016
  189. HWANG HS, Lee YT, Kim KH, Park S, et al
    Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Virology. 2016;494:215-224.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016